Radiation Therapy Compliance/Quality Assurance (QA) in 2 Phase 2 Trials of Cetuximab Plus Combined Modality Therapy (CMT) Including Chemotherapy and Radiation Therapy (RT) for Patients With Squamous Cell Carcinoma of the Anal Canal (SCCAC) (AMC045). - Garg, M.K.; Zhao, F.; Lee, J.; Sparano, J.; Palefsky, J.; Henry, D.; Wachsman, W.; Rajdev, L.; Aboulafia, D.; Mitchell, E.; Onitilo, A.; El-Rayes, B.; et al. (International Journal of Radiation Oncology, Biology, Physics, 2016)